| Literature DB >> 36104819 |
Ilana Levene1, Fiona Alderdice1, Beth McCleverty2, Frances O'Brien3, Mary Fewtrell4, Maria A Quigley5.
Abstract
BACKGROUND: Patient and Public Involvement (PPI) is a rich and valuable part of the process of planning, designing, carrying out and disseminating research. It is important to communicate PPI findings in detail so that the contributions of those involved are fully utilised and disseminated. The extended and iterative PPI process used within a neonatal randomised controlled trial related to the expression of breastmilk after very preterm birth is reported here.Entities:
Keywords: Breastfeeding; Human milk; Prematurity; Public engagement
Mesh:
Year: 2022 PMID: 36104819 PMCID: PMC9472727 DOI: 10.1186/s13006-022-00509-1
Source DB: PubMed Journal: Int Breastfeed J ISSN: 1746-4358 Impact factor: 3.790
Description of PPI stages complete, ongoing and planned
| Stage | Description | Demographic characteristics |
|---|---|---|
| 1. Informal PPI (complete) | Informal discussions with families over ten years of neonatal practice; personal experiences with expressing breastmilk and breastfeeding support communities; published qualitative literature and partnership prioritisation exercises | Varied family characteristics. Four of the authors involved at this stage had experiences related to expressing milk. |
| 2. Online Questionnaire (complete) | Online questionnaire with free text questions and prioritisation exercises. Advertised via Bliss (national charity for sick and preterm infants) | 675 contributors. 71% experienced birth before 32 weeks of pregnancy. 95% white ethnicity |
| 3. Charity Collaborator (complete) | Bliss staff members involved in creation of funding application and RCT protocol | Two staff members |
| 4. Online Panels (complete) | Two evening online panels. Contributors sent documents to review in advance. Discussion of trial design and documents encouraged. Role description provided in advance and payment offered as per INVOLVE guidance [ | Six contributors. Two from Black and other minority ethnic groups. One was under 25 years old |
| 5. RCT Intervention Modification Exercise (complete) | Contributors sent two draft intervention recordings. Focused questionnaires with feedback and recommendations. Role description provided in advance and payment offered as per INVOLVE guidance | 12 contributors. Four from Black and other minority ethnic groups. Two contributors with English as a second language. One was under 25 years old |
| 6. RCT Steering Committee (ongoing) | PPI contributors on the Trial Steering Committee attend meetings and are consulted when difficulties occur. Role description provided in advance and payment offered as per INVOLVE guidance. | One parent and one Bliss staff member |
| 7. Dissemination Panel (planned) | A PPI dissemination panel will be formed to discuss strategy and create resources. Best Beginnings (a national charity) will co-create printed resources for neonatal units | Study participants who consented for further contact will be invited |
Fig. 1Interaction of PPI stages with the research lifecycle, including future plans
Examples of the diverse range of answers to questions about what ‘success’ means to parents in relation to breastmilk feeding in prematurity
| Answers relating to the nature of the breastmilk feeding experience | Answers related to the duration of breastmilk feeding |
|---|---|
| Being able to express more milk | For longer than actually experienced |
| Minimising the effect of expressing on time spent with the baby | Until complementary feeds (“solids”) were introduced |
| Providing exclusive maternal milk | Until discharge from hospital |
| Any direct breastfeeding (getting the baby to latch to the breast at all) | Until the baby was perceived as less vulnerable to infection (for example after winter or when the baby had reached a particular weight) |
| Exclusive direct breastfeeding | Six months from birth |
| The mother being more happy or relaxed in relation to lactation | A year from birth |
| Feeling well supported | Until the baby was a toddler |
| Improving the baby’s weight gain | Until the baby or child decided they wanted to stop breastfeeding |
| Feeling listened to and trusted by staff |
Questions for future research on breastmilk expression, from PPI contributors, in order of frequency mentioned
| How to increase or maintain milk yield ( | |
| How frequently to express ( | |
| How long to express for at each session/optimal pattern of expressing ( | |
| How best to relax/feel comfortable or happy while expressing milk ( | |
| How much milk should be targeted/expected ( | |
| How best to store breastmilk ( | |
| The impact of delayed first expression/best timing ( | |
| How to minimise and manage over-supply ( | |
| Personalised likelihood of being able to express good volumes of milk ( | |
| The need for and impact of sterilisation processes for pump equipment ( | |
| How to reduce the occurrence of blocked milk ducts and mastitis ( | |
| Personalised expectations for the time for milk to ‘come in’ (lactogenesis II) ( | |
| The impact of antenatal expressing ( |
Fig. 2Respondents’ sources of information on lactation for preterm babies. Multiple options could be chosen from a pre-specified list
Questions for future research on direct breastfeeding in prematurity, from PPI contributors; in order of frequency raised
| How to help preterm babies attach to the breast ( | |
| How to make decisions on the need for gavage supplements when transition to direct breastfeeding has started ( | |
| When to try direct breastfeeding for the first time ( | |
| How to transition the breasts from expressing to direct breastfeeding ( | |
| The effect of “technology” (for example nipple shields, bottles, pacifiers) on the transition to direct breastfeeding ( | |
| How best to support mothers and partners’ lactation, physical and emotional needs ( | |
| Personalised likelihood of success at transitioning to any/exclusive direct breastfeeding, and how long the transition is expected to take ( | |
| What normal behaviour is for a breastfed preterm baby – for example feeding frequency, night waking, crying ( | |
| Impact of tongue-tie in prematurity ( |
Areas where PPI influenced the research. Inspired by the Public and Patient Engagement Evaluation Tool (PPEET)
| Type of influence | Amount of influence | PPI stage involved | Comment |
|---|---|---|---|
| Choice of population and intervention category | Moderate | Informal PPI (stage 1) | Set before formal PPI started |
| Choice of trial outcome measures | Large | Informal PPI (stage 1) Online Questionnaire (stage 2) Charity Collaborator (stage 3) | Formal PPI informed the choice of specific outcomes from a range of possibilities and their definitions (for example timepoint assessed) |
| Areas for exploratory analysis | Moderate | Informal PPI (stage 1) Online Questionnaire (stage 2) | Formal PPI confirmed areas of focus and provided more detail on questions of interest |
| Trial design – minimising adding to anxiety over milk yield | Large | Online Questionnaire (stage 2) Charity Collaborator (stage 3) Online Panels (stage 4) | Amendments to processes and documents |
| Trial design – minimising burden for participants | Large | Online Questionnaire (stage 2) Charity Collaborator (stage 3) Online Panels (stage 4) | Amendments to processes and documents. Some areas of tension decided by researchers |
| Trial modifications in response to challenges | Small | Trial Steering Committee (stage 6) | Consultation. Areas of disagreement decided by researchers |
| Intervention content | Very Large | Informal PPI (stage 1) Online Questionnaire (stage 2) RCT Intervention Modification Exercise (stage 5) | Iterative changes with detailed PPI input. Some disagreement among participants – final decision by researchers |
| Dissemination plan | Very Large | Online Questionnaire (stage 2) | Detailed list of vehicles of communication for dissemination provided by PPI, along with assessment of most significant channels |
| Future research topics | Large | Informal PPI (stage 1) Online Questionnaire (stage 2) | Broad range of questions posed |
The Public and Patient Engagement Evaluation Tool has been licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.©2018, Julia Abelson and the PPEET Research-Practice Collaborative. McMaster University. All rights reserved